甲状腺腺叶切除术用于高危特征T1b-T2期甲状腺乳头状癌
该研究利用美国国家癌症数据库分析2004-2014年间接受甲状腺腺叶切除术的T1b-T2期甲状腺乳头状癌成人患者,发现19.2%存在高危特征者本应行全甲状腺切除术,其10年总生存率低于适宜腺叶切除者(88.5% vs 92.4%,p<0.001),高危特征与更差生存独立相关(调整后HR 1.97,95%CI 1.51-2.58)。
要点
- T1b-T2期PTC行腺叶切除前需排除高危特征,否则可能影响长期生存。
- 高危特征包括cN1/pN1、脉管侵犯、甲状腺外侵犯、切缘阳性、低分化及M1。
- 高危特征患者行全甲状腺切除加放射性碘治疗生存优于不适宜腺叶切除(HR 0.65)。
核心结论
- 肿瘤>1cm且具有高危特征的甲状腺乳头状癌患者中,相当比例(19.2%)接受了腺叶切除术,而这类高危特征对长期生存有潜在不良影响。
- 高危特征患者行腺叶切除术的死亡风险显著高于无高危特征者(调整后HR 1.97,95%CI 1.51-2.58,p<0.001)。
研究设计与样本
- 基于美国国家癌症数据库(National Cancer Database)的回顾性队列研究,纳入2004-2014年间接受腺叶切除术的T1b-T2期甲状腺乳头状癌成人患者,共8,083例。
主要发现
- 8,083例接受腺叶切除术的患者中,1,552例(19.2%)具有高危特征,本应行全甲状腺切除术。
- 高危特征包括cN1 194例、pN1 571例、脉管侵犯307例、甲状腺外侵犯645例、切缘阳性567例、低分化42例、M1 25例。
- 10年随访时,适宜腺叶切除组92.4%存活,不适宜腺叶切除组88.5%存活(p<0.001)。
- 多因素Cox分析显示,年龄>45岁、男性、合并症、政府保险或无保险、低收入、肿瘤>2cm与更差生存相关(均p<0.05)。
- 全甲状腺切除加放射性碘治疗相比不适宜腺叶切除,总生存改善(HR 0.65,95%CI 0.51-0.83,p<0.001)。
临床怎么用
- 对T1b-T2期甲状腺乳头状癌拟行腺叶切除术时,应评估并排除高危特征(如淋巴结转移、脉管侵犯、甲状腺外侵犯、切缘阳性、低分化、M1)。
- 存在高危特征者应考虑全甲状腺切除术,必要时联合放射性碘治疗,以改善长期生存。
局限性
- 研究为回顾性数据库分析,可能存在选择偏倚和未测量混杂因素。
- 高危特征的定义和记录依赖于数据库编码,可能存在信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid lobectomy (TL) has been proposed as definitive surgical treatment for papillary thyroid cancers (PTC) up to 4 cm. This study evaluates the use and appropriateness of TL for T1b and T2 PTC. STUDY DESIGN: The National Cancer Database was interrogated for adult patients having TL for T1b-T2 PTC between 2004 and 2014. Patients who should have undergone total thyroidectomy (TT) instead of lobectomy based on high-risk tumor features were identified. The 2 groups were compared for clinical and demographic characteristics, and overall survival. RESULTS: Of 8,083 patients undergoing lobectomy, 1,552 patients had high-risk features and should have undergone TT. These included 194 with cN1, 571 with pN1, 307 with lymphovascular invasion (LVI), 645 with extra thyroidal extension (ETE), 567 with positive margins, 42 with poorly differentiated PTC, and 25 with M1 disease. At 10 years of follow-up, 92.4% of appropriate lobectomy (aTL) patients were alive compared with 88.5% of inappropriate lobectomy (iTL) patients (p < 0.001). On univariate and multivariable Cox survival analysis, age greater than 45 years, male sex, comorbidities, government or no insurance, low income, and tumor size >2 cm were associated with poorer survival (all p < 0.05). Thyroid lobectomy patients with high-risk features had significantly higher mortality on unadjusted (hazard ratio [HR] 1.98, 95% CI 1.52 to 2.59, p < 0.001) and adjusted survival analysis (HR 1.97, 95% CI 1.51 to 2.58, p < 0.001). Total thyroidectomy with radioiodine treatment had improved overall survival in comparison to iTL (HR 0.65, 95% CI 0.51 to 0.83, p < 0.001). CONCLUSIONS: A substantial number of patients (19.2%) with tumor size >1 cm and high-risk features undergo thyroid lobectomy for PTC. Exclusion of high-risk features is important when adopting lobectomy as the definitive surgical therapy for T1b and T2 PTC because they have a potential adverse effect on long-term survival.
引用
- Suman P, Razdan SN, Wang CE, et al. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features. J Am Coll Surg. 2019. PMID: 31672668. doi:10.1016/j.jamcollsurg.2019.09.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。